The immune-related signatures exhibited similar levels (namely, immune-checkpoint signatures) or displayed a higher inclination (GZMA, PRF1, CXCL9, CXCL10, and CCL5) in NTRK MT NSCLC in comparison to NTRK WT NSCLC. This evidence concerns the gene CCL5 and non-small cell lung carcinoma.